ChagasLAMP (GHIT G2020-203)
Field validation of Trypanosoma cruzi-LAMP: a molecular point-of-care test for the control of congenital Chagas disease
- Duración
- 01/04/2021 - 31/03/2023
- Coordinador
- Julio Alonso
- Financiadores
- Global Health Innovative Fund (GHIT)
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects ~7 million people, mostly in Latin America. Vector-borne transmission is on the way of being controlled in several countries, but vertical transmission remains an uncontrolled major public-health challenge. Remarkably, available drugs have a very high cure rate in T. cruzi-infected newborns if administered early upon infection, thus a timely diagnose is crucial for treatment success.
However, the algorithm to detect congenital T. cruzi infection involves parasitological methods that lack sensitivity and a serological study must be performed several months later. In many endemic regions, people live far from referral centres which entails that a large proportion of infants rarely go back for diagnosis confirmation and treatment, if infected. Consequently, they evolve to the chronic phase of the disease with the risk of developing severe manifestations.
Molecular-based diagnostics have a very high sensitivity to detect congenital T. cruzi infections, but laboratories in those distant regions are not equipped to perform them. With the aim to provide a suitable point-of-care (POC) test for the timely diagnosis of congenital Chagas disease in these settings, we will validate the implementation of EIKEN T. cruzi loop-mediated isothermal amplification (LAMP) prototype in the field.
Total Funding
¥ 147,127,368
Nuestro equipo
Coordinator
-
Julio Alonso Padilla Assistant Research Professor and Director of the Chagas Initiative
ISGlobal Team
-
Aina Casellas Torrentó
-
Laura Ferradino Research Assistant
-
Quim Gascon Research Professor, Head of the Chagas, Parasitic and Imported Diseases programme, and Director of the Chagas Initiative -
Susana Méndez Data manager -
Mirko Rojas Consultor y coordinador de campo en Bolivia -
Sergi Sanz Responsable de Departamento - Estadística
Otros proyectos
Ver proyectos pasadosNHEPACHA
Nuevas Herramientas para el Diagnóstico y la Evaluación del Paciente con Enfermedad de Chagas
Euroleish.net
Control of Leishmaniasis. From bench to bedside and community
GREPIMER
Grup de recerca en patología importada i malaties emergents i re-emergents
Diagnóstico y tratamiento del zika, dengue y chikunguña
Investigación aplicada al diagnóstico y tratamiento de los virus Zika, Dengue y Chikunguña
TcONTROL
Biomarcadores inmunológicos antígeno-específicos (células T) asociados al control de la infección por T. cruzi
XStrategy
Modelo y Herramienta para la construcción de estrategias para el incremento de la atención en Chagas
STOP
Towards the interruption of transmission of soil-transmitted helminths
TESEO
Nuevos regímenes de quimioterapia y biomarcadores para la enfermedad de Chagas
Datos de salud en población migrante
Mejora del sistema de recogida de datos de salud, en el marco del programa de atención sanitaria a la población migrante en Nador (Marruecos)
AVATAR
Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.
ECO
Equidad y Optimización del Acceso al Diagnóstico y Tratamiento de la COVID-19 en Bolivia y Paraguay
Herramienta innovadora de detección de enfermedades y vacunación a población inmigrante en riesgo en España
Project Code: PI21/00651